We know that there's going to be a favorable presentation on baricitinib next month. We know that management will give a professional-sounding presentation at the next CC. The arithmetic to put a $18 a share price on an Incyte-like company with the Jakafi franchise and nothing else is routine. So this seems like a very strange time for INCY to be weak.
jacosa; You are right on ! I am scratching my head while hold all longs that are leveraged to maxi...selling MO long everyday to keep statisfying margin call. ..I believe those two points you mentioned should lift stock price..I believe in this company future
Waiting for my Mountaineers to play so thought I would check in.... big problem for us now is the large % of shorts.... One of these days in the near future we get GREAT News and I can't wait to see those shorts smolder..... Yes TJ I am talking about you and your friends..